366 related articles for article (PubMed ID: 17177111)
1. Interaction of omeprazole with a methylated derivative of beta-cyclodextrin: phase solubility, NMR spectroscopy and molecular simulation.
Figueiras A; Sarraguça JM; Carvalho RA; Pais AA; Veiga FJ
Pharm Res; 2007 Feb; 24(2):377-89. PubMed ID: 17177111
[TBL] [Abstract][Full Text] [Related]
2. The role of L-arginine in inclusion complexes of omeprazole with cyclodextrins.
Figueiras A; Sarraguça JM; Pais AA; Carvalho RA; Veiga JF
AAPS PharmSciTech; 2010 Mar; 11(1):233-40. PubMed ID: 20135244
[TBL] [Abstract][Full Text] [Related]
3. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ
Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924
[TBL] [Abstract][Full Text] [Related]
4. A 1H NMR Study of Host/Guest Supramolecular Complexes of a Curcumin Analogue with β-Cyclodextrin and a β-Cyclodextrin-Conjugated Gemini Surfactant.
Poorghorban M; Karoyo AH; Grochulski P; Verrall RE; Wilson LD; Badea I
Mol Pharm; 2015 Aug; 12(8):2993-3006. PubMed ID: 26083126
[TBL] [Abstract][Full Text] [Related]
5. NMR spectra and structures of oridonin derivatives complexes with β-cyclodextrin.
Liu W; Zhao B; Li YC; Liu HM
Magn Reson Chem; 2011 Sep; 49(9):611-5. PubMed ID: 21815208
[TBL] [Abstract][Full Text] [Related]
6. Competitive displacement of drugs from cyclodextrin inclusion complex by polypseudorotaxane formation with poloxamer: implications in drug solubilization and delivery.
Nogueiras-Nieto L; Sobarzo-Sánchez E; Gómez-Amoza JL; Otero-Espinar FJ
Eur J Pharm Biopharm; 2012 Apr; 80(3):585-95. PubMed ID: 22182528
[TBL] [Abstract][Full Text] [Related]
7. Multimodal molecular encapsulation of nicardipine hydrochloride by beta-cyclodextrin, hydroxypropyl-beta-cyclodextrin and triacetyl-beta-cyclodextrin in solution. Structural studies by 1H NMR and ROESY experiments.
Fernandes CM; Carvalho RA; Pereira da Costa S; Veiga FJ
Eur J Pharm Sci; 2003 Apr; 18(5):285-96. PubMed ID: 12694880
[TBL] [Abstract][Full Text] [Related]
8. NMR (¹H, ROESY) spectroscopic and molecular modelling investigations of supramolecular complex of β-cyclodextrin and curcumin.
Jahed V; Zarrabi A; Bordbar AK; Hafezi MS
Food Chem; 2014 Dec; 165():241-6. PubMed ID: 25038672
[TBL] [Abstract][Full Text] [Related]
9. Promising applications in drug delivery systems of a novel β-cyclodextrin derivative obtained by green synthesis.
García A; Leonardi D; Lamas MC
Bioorg Med Chem Lett; 2016 Jan; 26(2):602-608. PubMed ID: 26642766
[TBL] [Abstract][Full Text] [Related]
10. Preparation and Spectroscopic Characterization of Inclusion Complexes of 3D Ball-Milled Rifampicin with β-cyclodextrin and γ-cyclodextrin : 3D Ball-Milled Rifampicin with β-cyclodextrin and γ-cyclodextrin.
Inoue Y; Shigematsu M; Komatsu T; Oguchi T; Arce FJ; See GL
AAPS PharmSciTech; 2022 May; 23(5):138. PubMed ID: 35534746
[TBL] [Abstract][Full Text] [Related]
11. Inclusion complex of colchicine in hydroxypropyl-β-cyclodextrin tenders better solubility and improved pharmacokinetics.
Chauhan R; Madan J; Kaushik D; Sardana S; Pandey RS; Sharma R
Pharm Dev Technol; 2013; 18(2):313-22. PubMed ID: 21699389
[TBL] [Abstract][Full Text] [Related]
12. Diloxanide furoate binary complexes with β-, methyl-β-, and hydroxypropyl-β-cyclodextrins: inclusion mode, characterization in solution and in solid state and in vitro dissolution studies.
Aloisio C; Longhi M
Pharm Dev Technol; 2018 Sep; 23(7):723-731. PubMed ID: 28758845
[TBL] [Abstract][Full Text] [Related]
13. Binding of sulfamethazine to β-cyclodextrin and methyl-β-cyclodextrin.
Zoppi A; Delrivo A; Aiassa V; Longhi MR
AAPS PharmSciTech; 2013 Jun; 14(2):727-35. PubMed ID: 23606009
[TBL] [Abstract][Full Text] [Related]
14. Inclusion interaction of chloramphenicol and heptakis (2,6-di-O-methyl)-β-cyclodextrin: phase solubility and spectroscopic methods.
Shi JH; Zhou YF
Spectrochim Acta A Mol Biomol Spectrosc; 2011 Dec; 83(1):570-4. PubMed ID: 21945123
[TBL] [Abstract][Full Text] [Related]
15. Cyclodextrin solubilization of the antibacterial agents triclosan and triclocarban: formation of aggregates and higher-order complexes.
Duan MS; Zhao N; Ossurardóttir IB; Thorsteinsson T; Loftsson T
Int J Pharm; 2005 Jun; 297(1-2):213-22. PubMed ID: 15885935
[TBL] [Abstract][Full Text] [Related]
16. Inclusion complex of erlotinib with sulfobutyl ether-β-cyclodextrin: Preparation, characterization, in silico, in vitro and in vivo evaluation.
Devasari N; Dora CP; Singh C; Paidi SR; Kumar V; Sobhia ME; Suresh S
Carbohydr Polym; 2015 Dec; 134():547-56. PubMed ID: 26428157
[TBL] [Abstract][Full Text] [Related]
17. Multicomponent complex formation between vinpocetine, cyclodextrins, tartaric acid and water-soluble polymers monitored by NMR and solubility studies.
Ribeiro L; Carvalho RA; Ferreira DC; Veiga FJ
Eur J Pharm Sci; 2005 Jan; 24(1):1-13. PubMed ID: 15626573
[TBL] [Abstract][Full Text] [Related]
18. Solubility and release modulation effect of sulfamerazine ternary complexes with cyclodextrins and meglumine.
Aloisio C; de Oliveira AG; Longhi M
J Pharm Biomed Anal; 2014 Nov; 100():64-73. PubMed ID: 25129645
[TBL] [Abstract][Full Text] [Related]
19. Preparation and solid-state characterization of inclusion complexes formed between miconazole and methyl-beta-cyclodextrin.
Ribeiro A; Figueiras A; Santos D; Veiga F
AAPS PharmSciTech; 2008; 9(4):1102-9. PubMed ID: 18975116
[TBL] [Abstract][Full Text] [Related]
20. Physicochemical and biological properties of 6(1),6(3),6(5)-tri-O-alpha-maltosyl-cyclomaltoheptaose (6(1),6(3),6(5)-tri-O-alpha-maltosyl-beta-cyclodextrin).
Okada Y; Semma M; Ichikawa A
Carbohydr Res; 2007 Jul; 342(10):1315-22. PubMed ID: 17498674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
